Drug Kinetics – News and Features

Researchers have manipulated a metabolic pathway in E.coli to create a strain that can produce an aromatic polyester.

Researchers at the University of Alabama at Birmingham discovered that combining regorafenib with a dual JAK/HDAC inhibitor significantly improves treatment efficacy for metastatic colorectal cancer while minimizing toxic side effects.

Researchers develop a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells.

Researchers developed a nanoparticle system that combines STING and TRL4 agonists with tumor-targeting agents. This method improved drug delivery and activated immune responses in pancreatic cancer mice models.

Learn from James Hallam, vice president of the Research, Development and Advanced Testing Business segment at Waters Corporation, about how technological advancements in mass spectrometry are powering new discoveries in omics research.

Certain mixtures of small organic molecules form interesting glasses and viscous liquids, offering promising candidates for replacing polymers in various products.

A tiny battery designed by MIT engineers could enable the deployment of cell-sized, autonomous robots for drug delivery within in the human body, as well as other applications such as locating leaks in gas pipelines.

Researchers at Johns Hopkins Children’s Center say they have developed four new regimens that have the potential to treat and save the lives of people with multidrug-resistant (MDR) tuberculous (TB) meningitis.

A new study provides important insights into the pharmacokinetics and safety of intravenous remdesivir in treating the SARS-CoV-2 coronavirus in pregnant women.

A new study shows that cells not classically part of the immune system trigger inflammation in celiac disease.